SAB Biotherapeutics, Inc.
SAB Biotherapeutics, Inc. (SABS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · SABS · as of Jun 9, 2026
Key Statistics
Explore SAB Biotherapeutics, Inc. Data
sabs stock data · financialsCompetitors & Peers
sabs competitorsSABS
ANTX
BOLD
EVAX
GBIO
ITRMAbout SAB Biotherapeutics, Inc.
SAB Biotherapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to advancing immunotherapies built upon human antibodies. The company leverages sophisticated genetic engineering and ant…
what is sab biotherapeutics, inc. · sabs stock overview · sab biotherapeutics, inc. company profile · who is sab biotherapeutics, inc. ceo · sabs NASDAQ · sab biotherapeutics, inc. headquarters · sab biotherapeutics, inc. business segments
About Stock Overview & Key Data
SAB Biotherapeutics, Inc. (SABS) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 9, 2021. As of the latest trading session, SABS stock price is $3.40, with a market capitalization of $32.5M. The stock has returned — over the past 12 months and — year-to-date.
Frequently Asked Questions
As of the latest trading session, SAB Biotherapeutics, Inc. (SABS) stock price is $3.40. The stock is traded on NASDAQ under the ticker symbol SABS. The 52-week range is $1.60 – $6.60.